• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Know Labs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    1/21/25 8:27:44 AM ET
    $KNW
    Industrial Machinery/Components
    Industrials
    Get the next $KNW alert in real time by email
    knwn_8k.htm
    0001074828false00010748282025-01-212025-01-21iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

     

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): January 21, 2025

     

    KNOW LABS, INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada

     

    001-37479

     

    90-0273142

    (State or other jurisdiction

    of incorporation)

     

    (Commission File Number)

     

    (IRS Employer

    Identification No.)

     

    619 Western Avenue, Suite 610, Seattle, Washington 

     

    98104

    (Address of principal executive offices)

     

    (Zip Code)

     

    (206) 903-1351

    (Registrant’s telephone number, including area code)

     

                                                                                                                                     

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

     

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading Symbol(s)

     

    Name of each exchange on which registered

    Common Stock, par value $0.001

     

    KNW

     

    NYSE American LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging Growth Company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

    Item 7.01 Regulation FD Disclosure.

     

    On January 21, 2025, Know Labs, Inc. (the “Company”) issued a press release announcing the formation of its new business unit, Know Labs Technology Licensing, dedicated to monetizing the Company’s intellectual property portfolio.

     

    The information included in this Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    99.1

     

    Press Release dated January 21, 2025

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     
    2

     

      

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: January 21, 2025

    KNOW LABS, INC.

     

     

     

     

     

    /s/ Ronald P. Erickson

     

     

    Name: Ronald P. Erickson

     

     

    Title: Chairman of the Board

     

     

     
    3

     

    Get the next $KNW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KNW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $KNW
    Leadership Updates

    Live Leadership Updates

    See more
    • Know Labs Appoints Chris Somogyi as President, International

      Somogyi to lead Know Labs' "Skunkworks" Program and drive global revenues. Know Labs, Inc. (NYSE:KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, International. With over 40 years of experience in commercializing innovation across related industries, Somogyi brings a wealth of expertise to lead the Company's "Skunkworks" Program and global patent licensing efforts. In his role, Somogyi will focus on identifying new applications of Know Labs' extensive intellectual property (IP) portfolio consisting of over 300 patents issued, pending and in-process and covering more than 100 medical and non-medical app

      5/16/24 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs Expands Medical and Scientific Advisory Board

      New Members Bring Extensive Clinical Diabetes Management and FDA Expertise Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of four new members to the Company's Medical and Scientific Advisory Board. The new additions to the Advisory Board are Jeff Hitchcock, Karmeen Kulkarni, Dr. Meng Tan and Dr. Satish Garg. They bring to the board extensive experience in clinical diabetes management, including the advancement of new technologies and innovation in medical diagnostics. The Medical and Scientific Advisory Board is chaired by Know Labs' Chief Medical Officer, Dr. James H. "Andy" Anderson. The Advisory Board p

      12/14/23 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs Expands Board of Directors

      Appoints Three New Directors with Deep Sector Expertise Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the appointment of three new members to the Company's Board of Directors. These appointments increase the number of Directors to seven. Each new Director brings to the board extensive sector-relevant experience with deep knowledge of the science and the marketplace that is the focus of Know Labs. The new appointees are John Cronin, Larry Ellingson and Tim Londergan. John Cronin is the founder and CEO of ipCapital Group, Inc., a leading global advisory company on intellectual property strategy and monetization. Cronin beg

      11/8/23 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials

    $KNW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy

      Know Labs, Inc. (NYSE American: KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has entered into an agreement with Goldeneye 1995 LLC ("Buyer"), an affiliate of fintech investor, entrepreneur, and former Ripple Chief Risk Officer, Greg Kidd, to acquire a controlling interest in the Company. Upon the closing of the transaction, Mr. Kidd will become Chief Executive Officer and Chairman of the Board of Directors of the Company. Under the terms of the agreement, the Buyer will acquire that number of shares of the Company's common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum t

      6/6/25 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time

      Significant Applications in Health Care, Food Quality and Safety and More Know Labs, Inc. (NYSE:KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology to identify changes in pH levels in real time. The research has been submitted for peer reviewed publication. The research is available for review today here on the Company's website at www.knowlabs.co. An abstract of the paper states, "We describe an experiment in which we employ a radio frequency sensor to measure pH changes in a liquid solution. The experiment is novel in a few ways. First, the sensor does not have cont

      3/19/25 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

      The company to meet with potential strategic partners to discuss collaborating on advancing clinical research of its non-invasive blood glucose monitor Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology with its Radio Frequency Dialectic Spectroscopy (RFDS) platform, today announced the company will be attending The 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Technology Fair in Amsterdam, Netherlands on March 19-22, 2025. The Company will share updates on the development of its non-invasive blood glucose monitor, since last year's conference, and discuss opportunities for collaboration and partnership

      3/18/25 9:00:00 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials

    $KNW
    SEC Filings

    See more
    • Know Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - KNOW LABS, INC. (0001074828) (Filer)

      6/6/25 9:00:35 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

      8-K - KNOW LABS, INC. (0001074828) (Filer)

      6/4/25 5:07:06 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-Q filed by Know Labs Inc.

      10-Q - KNOW LABS, INC. (0001074828) (Filer)

      5/14/25 4:24:08 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials

    $KNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by CEO Erickson Ronald P

      4 - KNOW LABS, INC. (0001074828) (Issuer)

      6/4/25 4:15:21 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Director Takesako Ichiro John Paul was granted 25,000 shares, increasing direct ownership by 645% to 28,875 units (SEC Form 4)

      4 - KNOW LABS, INC. (0001074828) (Issuer)

      5/7/25 4:16:32 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Director Ellingson Larry K was granted 25,000 shares, increasing direct ownership by 6,188% to 25,404 units (SEC Form 4)

      4 - KNOW LABS, INC. (0001074828) (Issuer)

      5/7/25 4:16:34 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials

    $KNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Know Labs Inc. (Amendment)

      SC 13D/A - KNOW LABS, INC. (0001074828) (Subject)

      6/3/24 2:11:39 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13D filed by Know Labs Inc.

      SC 13D - KNOW LABS, INC. (0001074828) (Subject)

      10/25/23 7:27:11 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13D/A filed by Know Labs Inc. (Amendment)

      SC 13D/A - KNOW LABS, INC. (0001074828) (Subject)

      10/19/23 6:32:18 AM ET
      $KNW
      Industrial Machinery/Components
      Industrials

    $KNW
    Financials

    Live finance-specific insights

    See more
    • Know Labs, Inc. Reports Third Quarter FY2023 Results

      Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter ended June 30, 2023. Financial Highlights: Know Labs reported a net loss of $3.59 million dollars in the third quarter of 2023, compared to a net loss of $3.03 million dollars in the year-ago period, which translates to Earnings Per Share of a loss of $0.07, unchanged from the year ago period of a loss of $0.07 before preferred stock dividends. Recorded a non-cash charge to earnings of $4.96 million related to the fair market value of dividends on the Company's Series C and D preferred stock, that were either paid or accrued in share

      8/14/23 4:15:00 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs, Inc. Reports Second Quarter FY2023 Results

      Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter ended March 31, 2023. Financial Highlights: Know Labs reported a net loss of $4.93 million dollars in the second quarter of 2023, compared to a net loss of $6.14 million dollars in the year-ago period, which translates to Earnings Per Share of a loss of $0.10, an improvement over the year ago period of a loss of $0.16. Research and development expense for the second quarter was $2.56 million dollars as compared to $1.25 million dollars in 2022. The increase in R&D expense was related to staff increases in engineering, third party te

      5/15/23 4:05:00 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials
    • Know Labs, Inc. Reports First Quarter 2023 Results

      Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the first quarter ended December 31, 2022. Financial Highlights: Know Labs reported a net loss of $3.82 million in the first quarter of 2023, compared to a net loss of $5.36 million in the first quarter of 2022, which translates to Earnings Per Share of a loss of $0.08 versus a loss of $0.15 in the year ago period. Research and development expense for the first quarter ended December 31, 2022, was $1.74 million as compared to $886,000 in the same year ago period. The increase in R&D expense was related to staff increases in engineering, third party techn

      2/14/23 4:00:00 PM ET
      $KNW
      Industrial Machinery/Components
      Industrials